Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study. - Abstract - Europe PMC
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale OneFile: Health and Medicine
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale Academic OneFile
Frontiers | Identifying Common Genetic Risk Factors of Diabetic Neuropathies
Identifying common genetic risk factors of diabetic neuropathies
Rare Coding Variation and Risk of Intracerebral Hemorrhage
Identifying common genetic risk factors of diabetic neuropathies
Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin | Lipids in Health and Disease | Full Text
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study. - Abstract - Europe PMC
Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms | PGPM
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale Academic OneFile
Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin | Lipids in Health and Disease | Full Text
Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms | PGPM
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale Academic OneFile
Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms | PGPM